Cocrystal Pharma Inc.

NASDAQ: COCP
Share price (1/3/25): $2.35
Market cap (1/3/25): $23.9 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Kornberg Roger D.

Pfenniger Richard C Jr

Frost Phillip MD Et Al

News Filter

To Extend Phase 2a Influenza Challenge Study With Oral PB2 Inhibitor CC-42344

Reports Third Quarter 2024 Financial Results and Provides Updates on Its Antiviral Drug-Development Programs

Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins

Change in Directors, Officers or Compensation

To Highlight Near-Term Clinical Milestones During Presentations at Two Upcoming Investment Conferences

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC